Mary EllenKleinhenzMD
Pulmonology • San Francisco, CACystic Fibrosis, Lung Transplantation Medicine, Pleural Disease
Health Sciences Clinical Professor, Medicine, UCSF School of Medicine
Dr. Kleinhenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2961Fax+1 415-353-2568
Summary
- Dr. Mary Ellen Kleinhenz is a pulmonologist in San Francisco, CA and practices at UCSF Medical Center. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 42 years. She specializes in cystic fibrosis, lung transplantation medicine, and Bronchiectasis from causes other than cystic fibrosis. She is experienced in transplant pulmonology and cystic fibrosis.
Education & Training
University of Alabama Medical CenterResidency, Internal Medicine, 1975 - 1978
Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
CA State Medical License 2004 - 2026
OH State Medical License 1978 - 1992
AL State Medical License 1976 - 1976- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 7 citationsPrimary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression.Nicholas A. Kolaitis, Ying Gao, Allison Soong, John R. Greenland, Steven R. Hays
American Journal of Transplantation. 2021-02-01 - 49 citationsMitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction.Beñat Mallavia, Fengchun Liu, Emma Lefrançais, Simon J. Cleary, Nicholas Kwaan
American Journal of Respiratory Cell and Molecular Biology. 2020-02-28 - 6 citationsNKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes.Daniel R Calabrese, Tasha Tsao, Mélia Magnen, Colin Valet, Ying Gao
JCI Insight. 2022-12-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
